Thursday, June 12, 2014

Cell-Based Assays Market by Product & Applications – 2018

Cell-based assays are rapidly gaining importance in the field of drug discovery, predictive toxicology and basic research. The global market is estimated to be valued at $8,734 million in 2013 and will grow at a CAGR of 11.1% from 2013 to 2018.
The cell-based assays market will witness a double-digit growth attributed to the increase in range of applications. Advantages over biochemical assays and animal models, government initiatives and public-private partnerships, and rising number of drug discovery practices are significant factors propelling the market in the forecast period. On the other hand, high cost of instruments, and maintenance of cell lines are the factors that hinder the market.
The global cell-based assays market is segmented on the basis of products, applications, and end users. The products market is further subdivided into consumables (including reagents and assay kits, microplates and cell lines), instruments (detection and screening instruments such as microplate readers, flow cytometers, label-free detection instruments fluorescence microscopes, high content screening instruments and automation and high throughput screening instruments), software and cell based assay development services. Major types of cell based assays captured in the report include cell growth assays, cell death assays, second messenger assays and reporter gene assays.
Based on applications, the cell-based assays market is categorized into basic research, drug discovery, ADME, predictive toxicology and other applications. Drug discovery represents the largest share of amongst these applications. With rapid developments in fields such as cell biology, genomics, proteomics and bioinformatics, the number of potential drug candidates has risen significantly, and so have the drug discovery studies.
Government initiatives and public-private partnerships along with drying drug pipeline in pharmaceutical industry have led to increase in drug discovery activities; which is stimulating the market growth. Presently, the market is all set to witness trends such as label free detection, drug discovery outsourcing, 3D culture and stem cells. However, the major hindrances to the growth of the market are high-cost associated with detection technologies and intellectual property issues for assay kits.
The key players in the cell-based assays market include BD Biosciences (U.S.), Danaher Corporation (U.S.), DiscoveRx (U.S.), EMD Millipore (Germany), GE Healthcare (U.K), Life Technologies Corporation (U.S.), PerkinElmer (U.S.), Corporation (U.S.) and Promega (U.S.).
Browse related reports
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) – Forecast to 2018.
http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) – Global Forecast to 2018
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan

North – Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Sample Preparation Market by Product & Application – 2018

The global sample preparation market is segmented on the basis of products, applications, and end users. Based on products the global market includes instruments, consumables, accessories and kits. Instruments are further classified into sample preparation workstations, liquid handling systems, extraction systems and others. Liquid handling systems comprises liquid handling workstations, pipetting systems, reagent dispensers, microplate washers and others.
The consumables comprise filters, columns, tubes, plates and others. Accessories include caps, disposable bags/box, rod covers, adapters, tip and tube holder, plate carrier. Sample Preparation kits further segmented into Purification kits (DNA, RNA, Nucleic Acid and Protein), Extraction kits (DNA, RNA, Nucleic Acid and Protein), Isolation kits (DNA, RNA, Nucleic Acid and Protein), and others (Cell Lysis kits and Clean- up kits).
Based on applications the global sample preparation market is broadly categorized into genomics, proteomics, epigenomics and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (ROW). The market by end users segmented into molecular diagnostics, pharmaceuticals & biotechnology, applied testing, and academic research institutes. In 2013, the molecular diagnostics accounted for the largest share of the global market, by end users.
A number of factors such as technological advancements in workstations, global alliances amongst leading research institutes to boost drug discovery, increasing life science and R&D spending, technological advancements in analytical instruments are propelling the growth of the sample preparation market. However, difficulty in developing ‘one-size-fits-all’ kits and high costs of workstations are the major factors hindering the growth of this market.
The major players in the global market includes Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc.(U.S.), QIAGEN N.V.( The Netherlands), PerkinElmer, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Corporation (U.S), Norgen Biotek Corporation (Canada), Hamilton Company (U.S.), Tecan Group Ltd. (Switzerland), Roche Applied Science (U.S), and Merck Millipore (U.S.).
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North – Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Thursday, March 27, 2014

Medical Gases and Equipment Market worth $14,953 Million by 2018

The “Medical Gases and Equipment Market by Gases (Oxygen, Medical Air, Nitrogen, Nitrous-oxide, Helium, Blood-gas Mixture, Nitrous Oxide-Oxygen Mixture), by Equipment (Cylinders, Manifolds, Regulators, Flowmeters) - Global Forecast to 2018” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.


The global market is estimated to be worth $10,416 million in 2013. The market is mainly driven by the growing aging population and the increasing home healthcare market. Advancements in technologies and devices coupled with the trend of continuous monitoring of diseases are also significantly compelling healthcare providers and payers to shift their focus from hospital care to home care settings.


The global medical gases and equipment market is segmented by product, application, and geography. By products, the market is broadly segmented into gases market and equipment market. The gases market is further segmented into medical pure gases and gas mixtures. The medical pure gases market covers gases like medical air, carbon dioxide, helium, nitrogen, nitrous oxide, and oxygen. Medical gas mixture is divided into blood gas mixtures, nitrous oxide-oxygen mixtures, carbon dioxide-oxygen mixtures, lung diffusion mixtures, laser gas mixtures, aerobic mixtures, and anaerobic mixtures. The equipment segment includes cylinders, vacuum systems, manifolds, regulators, suction regulators, flowmeters, hoses, outlets, and monitoring systems.

North America contributes the largest share to the global market, followed by Europe, Asia-Pacific, and Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The APAC region is expected to have the fastest market growth during the forecast period, largely driven by rapid growth in the developing healthcare industry across China and India.


The major players in the market include Linde Group (Germany), Praxair Inc. (U.S.), Air Products and Chemicals Inc. (U.S.), Air Liquide (France), Taiyo Nippon Sanso Corp. (Japan), Airgas Inc. (U.S.), Messer Group (Germany), Atlas Copco (Sweden), Matheson Tri Gas Inc. (U.S.), and SOL-SpA (Italy).


Wednesday, March 26, 2014

Dialysis Instrumentation Market worth $83.21 Billion by 2018

The report “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and Rest of the World.


The global market is valued at $61.60 billion in 2013 and is expected to reach $83.20 billion by 2018, at a CAGR of 6.2% from 2013 to 2018.

In the report, the market has been segmented into hemodialysis and peritoneal products and services. The Hemodialysis products and services segment held the largest share of 85% in the global market, in 2012. Furthermore, the market has also been segmented on the basis of category (hemodialysis and peritoneal dialysis) and end-users (in-center dialysis and home dialysis). Inclination of patients towards home hemodialysis and nocturnal hemodialysis treatments exhibits a high growth potential for industry players in the near future.


North America holds the largest share of the global market. However, in the forthcoming years, developing regions such as Asia-Pacific (Japan, China, South Korea, and India), Latin America, and the Middle East are expected to form new revenue generating pockets for the market players. Economic developments, the presence of a large patient population, the growing number of dialysis centers, rising incidence and prevalence of diabetes and hypertension, and increasing government initiatives to develop/improve dialysis care are the key factors that drives the growth of the market in developing regions.


The market is majorly dominated by a few players such as Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners Inc. (U.S.), Gambro AB (Sweden), Baxter International Inc. (U.S.), and B. Braun Melsungen AG (Germany). Fresenius Medical Care holds the leading position in the market with a share of ~24% in 2013. Partnerships and collaborations are the key strategies adopted by market players to ensure their growth in the market. The introduction of the bundle reimbursement system has further lead to an increase in the number of collaborative partnerships among industry participants.



Tuesday, March 11, 2014

Disposable Medical Devices Sensors Market worth $6,212.7 Million by 2018


The “Disposable Medical Devices Sensors Market - By Type [Biosensor, Image sensor, Accelerometer] Monitoring[Smart Pill, Pulse Oximeter] Diagnostic[Capsule Endoscope, Blood Glucose Strip] Therapeutic[Insulin pump, Dialysis]- Global Forecast to 2018”, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.


Early buyers will receive 10% customization in this report.

This report studies the global disposable devices sensors market over the forecast period of 2013-2018. The market is valued at an estimated $3,831.6 million in 2013 and is poised to grow at a CAGR of 10.1% from 2013 to 2018, to reach $6,212.7 million by 2018.

Request Sample:

Across the globe, sensor-based disposable devices are being increasingly used due to factors such as lower cost and their ability to reduce hospital acquired infections. A number of sensor-based disposable devices are available in the market. Furthermore, companies are engaged in developing new disposable devices sensors with advanced feature, which will help the market to grow further.

Enquiry before Buying:

The disposable medical devices sensors market is a highly fragmented market, as various segments have different leaders that depend on their expertise and product offerings. For instance, the capsule endoscopes market is dominated by Given Imaging (Israel), followed by Olympus Corporation (Japan). Various new entrants are entering the disposable devices sensors market, which increases the competition amongst players. The report provides an in-depth industry analysis (Porter’s five forces analysis) and opportunity analysis for established players as well as new entrants. The report also covers novel technologies that are expected to fuel the market in the near future. The product life cycle identifies products with the highest growth opportunities and the factors that propel and hinder their growth. The report also includes an analysis of benchmarking strategies adopted by leading players in the market for enhancing their market share and presence.